Geron Corporation(GERN)Earnings, Financials & Key RatiosGeron Corporation (GERN) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
while the 97.4% gross margin profile is attractive, the $62.9 million operating cash outflow in 2026Q1 suggests that the company remains highly dependent on external capital to sustain its commercial operations.
Geron Corporation (GERN) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Geron Corporation (GERN) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 6, 2026 | $0.01vs $0.03+66.7% | $52Mvs $51M+2.5% |
| Q1 2026 | Feb 25, 2026 | $0.03vs $0.03+0.0% | $48Mvs $50M-4.8% |
| Q4 2025 | Nov 5, 2025 | $0.03vs $0.04+18.2% | $47Mvs $53M-11.5% |
| Q3 2025 | Aug 6, 2025 | $0.02vs $0.03+33.3% | $49Mvs $47M+3.7% |
Recent stock market news and headlines for Geron Corporation (GERN)
FOSTER CITY, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial stage biopharmaceutical company, today reported that, effective June 17, 2026, it granted stock options to purchase an aggregate of 690,000 shares of common stock to eight newly hired employees as an inducement material to such employees' acceptance of employment with Geron.
Key metrics vs top competitors for Geron Corporation (GERN)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.27 | $814.73M | -9.77 | 138.83% | -46.65% | -33.89% | — | |
| $38.14 | $7.83B | -13.77 | — | — | -68.16% | — | |
| $114.20 | $9.32B | -30.95 | -16.72% | -612.17% | -25.02% | — | |
| $81.35 | $6.75B | 10.46 | 114.51% | -22.58% | — | — | |
| $53.52 | $8.19B | 19.32 | 87.32% | 65.95% | 87.36% | — | |
| $2.11 | $514.56M | -2.43 | -100% | — | -56.45% | — |
Geron Corporation (GERN) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Geron Corporation (GERN) SEC filings — annual & quarterly reports (10-K, 10-Q)
Mar 26, 2026·SEC
Feb 25, 2026·SEC
Jan 12, 2026·SEC
Get notified when GERN posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Geron Corporation (GERN) stock FAQ — growth, dividends, profitability & financials explained
Geron Corporation (GERN) reported $196.1M in revenue for fiscal year 2025. This represents a 3600% increase from $5.3M in 1996.
Geron Corporation (GERN) grew revenue by 138.8% over the past year. This is strong growth.
Geron Corporation (GERN) reported a net loss of $69.6M for fiscal year 2025.
Geron Corporation (GERN) has a return on equity (ROE) of -33.9%. Negative ROE indicates the company is unprofitable.
Geron Corporation (GERN) had negative free cash flow of $126.3M in fiscal year 2025, likely due to heavy capital investments.
